Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Deloitte
US Department of Justice
Johnson and Johnson
Colorcon
McKesson
Harvard Business School
Covington
McKinsey
Boehringer Ingelheim

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019593

« Back to Dashboard

NDA 019593 describes ZANTAC IN PLASTIC CONTAINER, which is a drug marketed by Teligent and is included in one NDA. Additional details are available on the ZANTAC IN PLASTIC CONTAINER profile page.

The generic ingredient in ZANTAC IN PLASTIC CONTAINER is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. One hundred and forty-three suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for 019593
Tradename:ZANTAC IN PLASTIC CONTAINER
Applicant:Teligent
Ingredient:ranitidine hydrochloride
Patents:0
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 50MG BASE/100ML
Approval Date:Dec 17, 1986TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:Sep 27, 1991TE:RLD:No

Expired US Patents for NDA 019593

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-001 Dec 17, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Teligent ZANTAC IN PLASTIC CONTAINER ranitidine hydrochloride INJECTABLE;INJECTION 019593-002 Sep 27, 1991 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Baxter
Covington
McKinsey
Queensland Health
Cerilliant
Fish and Richardson
Johnson and Johnson
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot